Corvex & Soroban Add To Williams Companies Position

Keith Meister's activist hedge fund Corvex Management and Eric Mandelblatt's Soroban Capital have filed an amended 13D with the SEC regarding their position in Williams Companies (WMB).  Per the filing, the hedge funds have disclosed they now own 6.74% of WMB with over 46 million shares.

The filing indicates their latest activity was on January 9th, 2014 and this stake is up from the previous 5% of the company they owned.  We initially highlighted when these hedge funds went activist on Williams last month.

Keep in mind, however, that their position disclosure is not inclusive of cash-settled swaps and options which reference an additional 21.3 million shares.  If you add in this exposure, they would own 9.86% of the company.

Per Google Finance, Williams Companies is "an energy infrastructure company focused on connecting North America’s hydrocarbon resource plays to markets for natural gas, natural gas liquids (NGLs), and olefins. Its operations span from the deepwater Gulf of Mexico to the Canadian oil sands. It operates in three segments: Williams Partners, Midstream Canada & Olefins and Other. Its interstate gas pipeline and domestic midstream interests are held through its investment in Williams Partners L.P. (WPZ). It owns the general-partner interest and a 70% limited-partner interest in WPZ. Williams also owns a Canadian midstream and domestic olefins production business, which processes oil sands off-gas and produces olefins for petrochemical feedstocks."

Avenue Capital Discloses Punch Taverns Position

Marc Lasry's Avenue European Management hedge fund has been building a stake in London listed pub company Punch Taverns (LON:PUB). 

Due to trading on the 6th and 10th of January, Avenue now own the equivalent of 8.29% of Punch Taverns' voting rights, all via contracts for difference/derivatives.

Avenue know the company well as Lasry mentioned in an NYT interview in 2012 that they held a position in Punch's debt.

Larry Robbins' Glenview Capital Management are Punch Taverns' largest shareholder with an 18.77% stake which they have held for over five years.

Per Google Finance – “Punch Taverns plc is a United Kingdom-based pub company. The Company is  engaged in the operation of public houses under either the leased model or as directly managed by   the Company. The Company operates in two business segments: punch partnerships, a leased estate   and punch pub company, a managed estate. Punch Partnerships is the Company’s leased division,   comprising 5,967 pubs nationwide. Punch Pub Company is its managed division, comprising 803   pubs nationwide. The leased model involves the granting of leases to tenants who operate the pub   as their own business, paying rent to the Company, purchasing beer and other drinks from it and   entering into profit sharing arrangements for income from leisure machines. Pubs that are directly   managed involve the employment of a manager to operate each managed pub.

Lone Pine Capital Adds to Wyndham Stake

Steve Mandel's hedge fund firm Lone Pine Capital has filed a 13G with the SEC regarding their position in Wyndham Worldwide (WYN).  Per the filing, Lone Pine now owns 5.2% of WYN with over 6.77 million shares.

The filing indicates they've purchased over 1.06 million shares since the end of the third quarter and the 13G was filed due to portfolio activity on January 2nd, 2014.

Per Google Finance, Wyndham Worldwide is "a hospitality company. The Company offers individual consumers and business customers an array of hospitality services and products across various accommodation alternatives and price ranges through its portfolio of brands. It operates in three segments of the hospitality industry: lodging, vacation exchange and rentals and vacation ownership. Its brands include Wyndham Hotels and Resorts, Tryp by Wyndham, Ramada, Days Inn, Super 8, Landal GreenParks, Novasol, Hoseasons, cottages4you, James Villa Holidays, ResortQuest by Wyndham Vacation Rentals, The Resort Company by Wyndham Vacation Rentals, Wyndham Vacation Resorts and WorldMark by Wyndham."

For more portfolio activity from Lone Pine, click here.

NYU Stern Evaluation Investment Newsletter: Roderick Wong, Aswath Damodaran, James Rosenwald & More

Today we wanted to share the inaugural issue of NYU Stern's student-run investment newsletter: Evaluation.  It features interviews with Professor Aswath Damodaran (whose work we've linked to many times), James Rosenwald of Dalton Investments, as well as Roderick Wong of RTW Investments, among others.

This newsletter differs from others in that it is geared toward those early on in their careers or those looking to get into investing/research.

The interviews in this first issue take you inside the lives of established portfolio managers, young buyside alumnus, young sell-side alumnus, and academics. 

Lastly, it also features two investment pitches from students: long Charter Communcations (CHTR) and short Peugeot (ENXTPA:UG).

Embedded below is NYU Stern's inaugural student newsletter:


 

Baupost Group Starts Kindred Biosciences Stake, Trims Enzon Pharmaceuticals Position

Seth Klarman's investment firm Baupost Group has filed 2 separate 13G's with the SEC.

Discloses New Position in Kindred Biosciences (KIN)

Baupost has disclosed a brand new stake in Kindred Biosciences (KIN).  Per the SEC filing, the firm now owns 17.93% of the company with 2.9 million shares.  The filing was required due to portfolio activity on December 31st.  Shares of KIN just started trading in December.

Per Google Finance, Kindred Biosciences is "a development-stage biopharmaceutical company. The Company focused on pets. In addition, it has seven other product candidates, including several biologics, in various stages of development. The Company’s product candidates are CereKin for the treatment of osteoarthritis pain and inflammation in dogs, AtoKin for the treatment of atopic dermatitis in dogs, and SentiKin for the treatment of post-operative pain in dogs. All of these product candidates, if approved, would be first-in-class drugs in the pet therapeutic market. The Company’s product pipeline consists of small molecules and biologics in various stages of development for a range of indications in dogs, cats and horses. Small molecules are generally chemical compounds administered orally and biologics are generally proteins and vaccines administered by injection."


Trims Enzon Pharmaceuticals (ENZN) Stake

The hedge fund also filed an amended 13G on Enzon Pharmaceuticals (ENZN) and disclosed they've sold over 3.35 million shares recently.  The filing was required due to activity on December 31st.  After these sales, Baupost still owns 9.84% of ENZN with over 4.33 million shares.

Per Google Finance, Enzon Pharmaceuticals is "a biotechnology company. The Company’s drug development programs utilize two platforms: Customized PEGylation Linker Technology (Customized Linker Technology) and third-generation messenger ribonucleic acid (mRNA) antagonists utilizing the Locked Nucleic Acid (LNA) technology. The Company has four compounds in human clinical development, a PEGylated version of the active metabolite of the cancer drug, irinotecan, PEG-SN38, and mRNA antagonists Survivin and the Androgen Receptor (AR). In addition, it has mRNA antagonist targets in various stages of preclinical research. The Company receives royalty revenues from licensing arrangements with other companies related to sales of products developed using its Customized Linker Technology-PEGINTRON. It is also using LNA technology to develop mRNA antagonists against oncology targets."


While it's always interesting to monitor Baupost's equity activities, keep in mind that their long equity book is only a small portion of their large overall assets under management (AUM).  For more on this hedge fund, we've posted up some of Baupost's other portfolio activity here.

What We're Reading ~ Hedge Fund Links 1/10/14

It's always relative.. that is, in performance [All About Alpha]

The obsession of John Paulson [AI-CIO]

Hedge funds cut 2 & 20 pricing [Fool]

Ackman issues status update on Herbalife [ZeroHedge]

Loeb takes position in Hertz, sources say [CNBC]

Jeff Ubben warns on let-down of activist investment boom [FT]

Update on Julian Robertson's new seeding platform [Dealbook]

On hedge fund proteges [Research Puzzle]

Third Point alum Bow Street bullish on media & telecom [ValueWalk]

Rare videos of Steve Cohen asked about securities laws [PBS]

Agecroft Partners' top 10 hedge fund industry predictions [FINalternatives]

Abenomics drives Japan hedge funds to world's top performers [Bloomberg]

China proves better bet than Japan for Asia hedge fund investors [HedgeWorld]

After scandal, SAC alums raising piles of cash [CNBC]

Harbinger knocks Dish's bid for Lightsquared's spectrum [HedgeWorld]

What We're Reading ~ Analytical Links 1/8/14

Investors/entrepreneurs predict trends, stocks & private companies to watch in 2014 [Forbes]

Compilation of what a lot of people learned in 2013 [Reformed Broker]

Individual investor stock allocation hits post-crisis high [Pragmatic Capitalism]

The world economy's shifting challenges [George Soros]

The best financial advice I ever got (or gave) [WSJ]

The 2014 buy list from [Crossing Wall Street]

Winners of 2013: boring investors [WSJ]

Why the P/E ratio doesn't always matter but cash flow is crucial [ValueWalk]

More 2014 predictions from market watchers [Yahoo Finance]

Liberty Media seeks full ownership of Sirius XM [Dealbook]

Billionaire Malone returns to empire building amid cord cutting [Bloomberg]

Hertz eyes sale of equipment rental unit [FT]

Venture Capitalists predict where they'll invest in 2014 [Forbes]

The art of misdirection [TED]

The 'internet of things' could be the next industrial revolution [DenverPost]

Ruffer Q4 Letter: Bulls Vs. Bears

Jonathan Ruffer is out with his Ruffer Investment Company fourth quarter letter.  In it, he highlights how there are currently two schools of thoughts when it comes to approaching the current markets:

"Those who are bearish, looking only at the fundamentals are forced to wait it out in the rising water, and it will be a matter of whether they can hold their nose and/or their nerve for long enough while the indices grind higher. Those who are bullish, whether through sunny optimism or a canny judgement of the situation, watch the Federal Reserve for some indication as to when they plan to pull away the punchbowl."

So, who flinches first?

Embedded below is Ruffer's Q4 letter:




For more from Ruffer, head to his Q3 letter on how he still anticipates eventual inflation.

Pershing Square Files 13D on Howard Hughes (HHC)

Bill Ackman's hedge fund Pershing Square Capital Management has filed an amended 13D with the SEC regarding their position in Howard Hughes (HHC).  Per the filing, Pershing has disclosed a 26.2% ownership stake in HHC via aggregate economic exposure of 10.88 million shares.

The main takeaway here is their swaps exposure to the name. They own 3.56 million common shares, Series A-2 warrants to purchase an additional 1.9 million shares, as well as 5.39 million shares of notional exposure via cash-settled total return swaps.  All of this exposure adds up to their 26.2% stake.

Per Google Finance, Howard Hughes is "a developer and operator of master planned communities and mixed use properties. The Company operates three segments: master planned communities, operating assets and strategic developments. The Company specializes in the development of master planned communities and ownership, management and the redevelopment or repositioning of real estate assets generating revenues, also called operating assets, as well as other strategic real estate opportunities in the form of entitled and unentitled land and other development rights, also called strategic developments."

For more on this hedge fund manager, head to Bill Ackman's latest presentation on Herbalife.

Starboard Value Goes Activist on Darden Restaurants (DRI) Too

Another activist has joined the Darden Restaurants (DRI) fight.  Jeffrey Smith's Starboard Value LP has disclosed a 5.55% stake in DRI with 7,250,000 shares via an activist 13D filing.

Last week, we highlighted Barington Capital's presentation on Darden Restaurants (DRI) where they called for the company to split up.  The company responded by announcing plans to spin off its Red Lobster chain. Now another activist is on the scene.

This is a brand new investment for Starboard.  They've engaged management in discussions and feel the announced plan doesn't maximize shareholder value.  Smith's 13D says,

"Specifically, Starboard believes there is a significant opportunity to dramatically improve the operating performance at the Issuer, as well as opportunities to realize substantial value from the Issuer’s real estate holdings and to explore other strategic options available to the Issuer to maximize shareholder value, including alternative business sale or separation transactions."

The company operates restaurants such as Olive Garden, Red Lobster, LongHorn Steakhouse, The Capital Grille, Yard House, Bahama Breeze, Seasons 52, and Eddie V's Prime Seafood.

For more on Starboard, see Jeff Smith's presentation on Wausau Paper.

Blue Ridge Capital Starts PBF Energy Stake

John Griffin's hedge fund firm Blue Ridge Capital filed a 13G with the SEC on shares of PBF Energy (PBF).  Per the filing, the hedge fund now shows a 7.82% ownership stake in the company with 3,095,000 shares.

This is a brand new position for Blue Ridge as they did not own a stake as of the end of the third quarter.  The filing was required due to portfolio activity on December 10th.

Per Google Finance, PBF Energy is "an independent petroleum refiners and suppliers of unbranded transportation fuels, heating oils, petrochemical feedstocks, lubricants and other petroleum products in the United States. The Company produces a range of products at each of its refineries, including gasoline, ultra-low-sulfur diesel (ULSD), heating oil, jet fuel, lubricants, petrochemicals and asphalt. The Company sells its products throughout the Northeast and Midwest of the United States, as well as in other regions of the United States and Canada, and are able to ship products to other international destinations."

You can view additional recent portfolio activity from Blue Ridge here.

Perry Capital Trims North American Energy Partners Position Again

Richard Perry's hedge fund firm Perry Capital has filed an amended 13D with the SEC regarding its position in North American Energy Partners (NOA).  Per the filing, Perry has disclosed a 4.75% ownership stake in NOA with 1,726,968 shares.

This marks around a 62% reduction in their position size as they've sold over 2.8 million shares since the end of the third quarter.  The filing indicates they sold shares at a price of $6 per share on December 19th.

This is also the second time they've trimmed their stake, as we highlighted Perry's NOA sales back in late October.

Per Google Finance, North American Energy Partners "provides a range of heavy construction and mining and pipeline installation services to customers in the Canadian oil sands, industrial construction, commercial and public construction and pipeline construction markets. The Company’s primary market is the Canadian oil sands, where it supports the customers’ mining operations and capital projects. NAEPI provides services through all stages of an oil sands project’s lifecycle, its core focus is on providing recurring services, such as contract mining, during the operational phase."

What We're Reading ~ Hedge Fund Links 12/20/13

Are commercial mortgages the next big thing for hedge funds? [CNBC]

Hedge funds cut fees to win big investors [FT]

Jim Chanos, bad news bear, urges market prudence [Reuters]

Many hedge funds launching traditional long-only strategies [TheAsset]

Managed accounts take the hassle out of hedge funds [Financial Standard]

Bill Miller to start fund with son under family name [Bloomberg]

Glenview Capital Adds to EVERTEC & Tenet Healthcare Stakes

Larry Robbins' hedge fund Glenview Capital filed a 13G and a Form 4 with the SEC disclosing some of their latest portfolio activity.


Glenview Adds to EVERTEC

Their 13G reveals activity in shares of EVERTEC (EVTC).  Per the filing, Glenview now owns 5.64% of the company with over 4.4 million shares.

This means they've doubled their stake since the end of the third quarter, when they initially built their position.  EVTC IPO'd in Q2 of this year.

Glenview's filing was required due to portfolio activity on December 9th.

Apollo has been the largest institutional shareholder, but one of its affiliates recently announced it would be selling 15.2 million shares in a secondary.  Other hedge funds are involved such as Corvex Management, Marble Arch Investments, and Pine River Capital.

Per Google Finance, EVERTEC is "formerly Carib Latam Holdings, Inc., is a full service transaction processing business in Latin America and the Caribbean. The Company provides a range of merchant acquiring, payment processing and business process management services across 19 countries in the region. It processes over 1.8 billion transactions annually, and manages the electronic payment network for over 4,100 automated teller machines (ATM) and over 104,000 point-of-sale payment terminals. It is the merchant acquirer in the Caribbean and Central America and in Latin America. The Company owns and operates the ATH network, one of ATM and personal identification number debit networks in Latin America. In addition, it provides a suite of services for core bank processing, cash processing and technology outsourcing. It serves a diversified customer base of financial institutions, merchants, corporations and government agencies with technology solutions."


Glenview Buys More Tenet Healthcare

Robbins' fund also filed a Form 4 with the SEC and disclosed purchases in shares of Tenet Healthcare (THC) on December 17th & 18th.  In total, they bought 1 million shares at weighted average prices between $39.30 and $41.20.

After this purchase, they now own 12.9 million shares of THC.  This has been a longstanding (and highly profitable) investment for the hedge fund.

Robbins also recently made a rare media appearance to talk about healthcare and for-profit hospitals.

Marc Lasry Sees Opportunities in Europe: Interview

Yesterday, Avenue Capital's Marc Lasry appeared on CNBC to talk about markets and his latest positioning.

He noted they're still long J.C. Penney bonds and think things will work out as it's essentially a turnaround bet.  We've previously posted Lasry's presentation on JCP bonds.

They see opportunities in Europe due to the deleveraging and are also looking to do direct lending to take advantage.  He said you want to focus on equities in Southern Europe but bonds in Northern Europe.

Embedded below is the video of Marc Lasry's interview:



If you missed it, we also posted up Jamie Dinan's interview as well as Lee Cooperman's interview from the same segment.

Steven Drobny's New House of Money: Interview with Kyle Bass

Steven Drobny, previous author of The Invisible Hands: Hedge Funds Off the Record as well as Inside the House of Money, is coming out with a new book.  His new title, The New House of Money, continues his ongoing series of interviews with top hedge fund managers.

He'll be releasing a new chapter each month and the first chapter features Kyle Bass of Hayman Capital.  We've embedded the chapter below and you can access it at their website:




Be sure to check out Drobny's other great books as well interviewing notable hedge fund managers:

- The Invisible Hands: Hedge Funds Off the Record

- Inside the House of Money

Jamie Dinan Likes Airlines, Hertz & Sprint/T-Mobile: Interview

York Capital's James Dinan appeared on CNBC today and talked about his latest market views.

He said they own most of the major airlines and notes these companies are now being run like businesses and can make money even at $95 oil.

He specifically mentioned American Airlines (AAL) and thinks there's great optionality here as they've merged with US Air and will have a great management team.  While some of these mergers can be rocky at the start, he thinks the value will be realized.  This has been a big hedge fund trade as of late with the likes of David Tepper and Julian Robertson also being involved in many of these names.

Dinan's biggest position is Hertz (HTZ) and he says it's a consolidation play as they'll see cost savings and revenue synergies from the Dollar Thrifty merger as well as fleet rationalization.  A few quarters ago, our Hedge Fund Wisdom newsletter flagged this popular trade and posted a write-up on Avis Budget (CAR), another beneficiary of the consolidation.

York thinks that this environment is great for event-driven investing, especially due to low interest rates.  Dinan also sees earnings going up next year and thinks companies will continue to do buybacks.  He also said he likes Sprint (S) and T-Mobile (TMUS).


Here are the videos of Dinan's appearance:

Video 1


Video 2


Video 3


Video 4

Lee Cooperman Likes SunEdison & Sandridge, Sees Market as Fairly Valued

Lee Cooperman, founder of Omega Advisors, appeared on CNBC today to talk about some of his favorite positions and market thoughts.

He continues to feel the market is fairly valued, around 16x earnings.  He pointed out that bull markets end from excesses.  That said, he also notes that investors are "underinvested" in equities, mainly due to fallout from the beatdown they received in 2008 as they've been reticent to get back in stocks.  He thinks the S&P will trade in a range of 1,600 to 2,000.

Some of his favorite picks include SandRidge Energy (SD), Sprint (S), Monitise (MONI.L), Qualicorp.  A new name for them is Sunedison (SUNE), a solar energy play that's spinning off its money-losing semiconductor business.  Cooperman feels it can see $20.  He also thinks SD has the potential to double and points out that TPG-Axon has been involved in this one pushing for change.

Lee Cooperman Video 1:



Lee Cooperman Video 2:



We've highlighted some other portfolio activity from Cooperman here.

What We're Reading ~ Analytical Links 12/18/13

Six investment errors you are making right now [Bloomberg]

Barclay's 2014 stock picks in each sector [StreetInsider]

Lakewood Capital on Opko Health: the placebo effect [Seeking Alpha]

Samsung: uneasy in the lead [NYTimes]

Underdog against Amazon, Best Buy charges ahead [NYTimes]

BlackRock 2014 outlook [BlackRock]

Want to invest like Buffett?  Here's how [Marketwatch]

A look at the Anadarko / Tronox situation [Distressed Debt Investing]

8 money managers share their top picks for next year [Bloomberg]

Sell Icahn Enterprises [Barrons]

They hate the Fed [Roger Lowenstein]

How to use the media to sell a company [Buzzfeed]

50 unfortunate truths about investing [Business Insider]

Where to find the biggest ideas for your business [Forbes]

The habits of the world's smartest people [Entrepreneur]

Why a for-profit college set up a man with a fake job (on purpose) [Huffington Post]

A video explaining Bitcoin [AVC]

New York Times Business Best Sellers List

As 2013 draws to a close, we wanted to check in on and highlight The New York Times list of business best sellers this year.  While many investors focus on investment books (and rightly so), business books can also help you refine your approach in how you think about businesses.  Numbers 2, 5, 8, and 9 in particular will benefit investors.


New York Times Business Best Sellers List

1. Lean In by Sheryl Sandberg with Nell Scovell.  One of the top sellers for quite some time.  "The chief operating officer of Facebook urges women to pursue their careers without ambivalence."

2. Outliers by Malcolm Gladwell.  This has been read by many in the investment community.  "Why some people succeed - it has to do with luck and opportunities as well as talent."

3.  Extortion by Peter Schweizer. "A Hoover Institution fellow argues that politicians shape legislation in order to extract donations." 

4. The Everything Store by Brad Stone. "The story of Jeff Bezos and Amazon." 

5. Focus by Daniel Goleman. "The author of “Emotional Intelligence” relies on research on attention to argue that high achievement requires three kinds of focus." 

6. Hundred Percenters by Mark Murphy. "Challenging employees to perform at their highest level."

7. Do You Speak Shoe Lover? by Linda Meadow and Kelly Cook. "Stories from customers and employees of the shoe retailer DSW."

8. The Caterpillar Way by Craig T. Bouchard and James V. Koch. "A biography of Caterpillar Inc. as a tale of successful business management."

9. Thinking, Fast and Slow by Daniel Kahneman. Another widely read book in investment circles.  "The winner of the Nobel in economic science discusses how we make choices in business and personal life." 

10. Steve Jobs by Walter Isaacson. After reading this book, hedge fund legend Julian Robertson decided to sell his Apple shares.  "A biography of the entrepreneur, based on 40 interviews with him conducted over two years."


And if you want more investment-specific reading, head to our recommended reading lists.